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BY-NC-ND license (http://creativecomAbstract Background: Candida albicans, a common fungal pathogen that can cause opportu-
nistic infections, is regarded as an apparently asexual, diploid fungus. A parasexual cycle was
previously found between homozygotes with opposite mating type-like loci (MTLa/a).
Fluconazole-resistant strains had a higher proportion of MTL homozygotes, whereas MTL homo-
zygous C. albicans was found in only about 3.2% of clinical strains. MTL heterozygotes had a
low frequency (1.4  104) of whiteeopaque switching to MTL homozygotes in nature.
Methods: Here, a reference C. albicans strain (SC5314) was used in a fluconazole-induced
assay to obtain standard opaque MTL homozygous strains and first-generation daughter strains
from the fluconazole inhibition zone. Further separation methods were employed to produce
second- and third-generation daughter strains. Polymerase chain reaction analysis based on
MTL genes was used to define MTL genotypes, and microscopic observations, a flow-
cytometric assay, and an antifungal E-test were used to compare microbiological characteris-
tics.
Results: MTL homozygotes were found at a high frequency (17 of 35; 48.6%) in fluconazole-
induced first-generation daughter strains, as were morphological polymorphisms, decreased
DNA content, and modified antifungal drug susceptibility. High-frequency MTL homozygosityof Microbiology and Immunology, Taipei Medical University, 250, Wu-Hsing Street, Taipei 110, Taiwan.
tw (C.-H. Su).
to this work.
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fluconazole-induced daughter strains was reduced compared with their progenitor SC5314
and standard MTL homozygous strains.
Conclusion: Treatment with fluconazole, commonly used to treat invasive candidiasis, inhib-
ited the growth of C. albicans and altered its microbiological characteristics. Our results sug-
gest that fluconazole treatment induces the high frequency of loss of heterozygosity and
microbiological polymorphism in C. albicans.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Candida albicans, a common fungal pathogen that can
cause opportunistic infections, is increasingly being recog-
nized as a human pathogen in immunocompromised hosts,
such as premature infants, cancer chemotherapy patients,
solid-organ transplant recipients, and patients coinfected
with human immunodeficiency virus or undergoing immu-
nosuppressive treatment. C. albicans accounts for 50e60%
of invasive fungal infections in humans, and the mortality
rate of candidemia is higher (up to 61%).1,2 C. albicans is
regarded as a diploid, apparently asexual fungus. The fre-
quency of spontaneous white-to-opaque cell switching is
about 1.4  104 for C. albicans and about 102 for the
specific WO-1 strain, as revealed by phloxine B-containing
Lee’s medium. Mating type-like loci MTL(a/a) identified in
C. albicans are orthologous genes to mating-type loci
MAT(a/a) in Saccharomyces cerevisiae. Only MTL homozy-
gotes undergo white-to-opaque cell switching, and all in-
dividuals of strain WO-1 and 3.2% of 220 clinical isolates
were found to be MTL homozygotes.3e6 Opaque cells are
106 times more mating competent than white cells. The
tetraploid parasexual cycle of C. albicans consisting of
mating followed by chromosome loss has been described
previously.7e9
Fluconazole is among the most common antifungal drugs
to treat invasive fungal diseases caused by C. albicans;
thus, much attention has been paid to fluconazole-resistant
C. albicans strains.10,11 A significantly higher proportion of
MTL homozygosity was found in the fluconazole-resistant
group than in the fluconazole-susceptible group among
clinical strains.12,13 However, fluconazole resistance is not
directly affected by MTL homozygosity. One study of the
evolution of fluconazole resistance was conducted to obtain
a series of 330-generation daughter strains by treating one
clinical strain with and without fluconazole. Further studies
of the 330-generation series of C. albicans strains show that
they appeared to have gradually developed adaptations
against fluconazole through genomic evolution with corre-
sponding fluconazole-resistant genes, which has indirectly
correlated with MTL homozygosity.14,15 However, recent
analyses of these evolved strains indicated that rapid
acquisition of aneuploidy and fluconazole resistance
occurred within the first few generations.16 Fluconazole
resistance in C. albicans is due to both accumulated point
mutations and loss of heterozygosity (LOH); therefore, MTL
homozygosity is coincident with LOH on the left arm ofOu T-Y, et al., Fluconazole indu
s, Journal of Microbiology, Imchromosome 5, where two genes corresponding to flucon-
azole resistance, ERG11 and TAC1, are located. Recent
analyses of these evolved strains indicate that rapid
acquisition of aneuploidy and fluconazole resistance
occurred within the first few generations.17,18
In a recent study, we found that fluconazole induced
random chromosome loss and LOH in C. albicans, but the
frequency of LOH is unclear.19 Therefore, we collected
isolates and offspring that were treated by fluconazole for a
short term, calculated the frequency of LOH, and analyzed
microbiological polymorphism.
Methods
C. albicans strains
The strains used in this study are listed in Table 1. The C.
albicans reference strain SC5314 was used for its complete
genome sequence.6 A fluconazole-induced assay was used
to obtain 35 fluconazole-induced first-generation daughter
strains (FI-FGDSs) of SC5314. FI-FGDSs were analyzed MTL
locus, and the heterozygotes were further separated and
isolated by plating culture and micromanipulation to
selected 87 fluconazole-induced second-generation
daughter strains (FI-SGDSs) and 141 fluconazole-induced
third-generation daughter strains (FI-TGDSs).
Fluconazole-induced assay and strain purification
The strain SC5314 was treated with the fluconazole-induced
assay as described previously.19 Phloxine B distinguishes
opaque sectors and colonies by differentially staining them
red. The strain SC5314 was treated with a fluconazole-
containing disc (100 mg fluconazole per disc) or a flucona-
zole E-test strip (AB BIODISK, Solna, Sweden) on PBeYPD agar
(YPD plus 5 mg/mL phloxine B) for 12e16 hours at 30C. In this
period, an inhibition zone was formed, and cells in the inhi-
bition zone were observed using a microscope. The 35 FI-
FGDSs were isolated from the inhibition zone with needle
and each colony was spread on YPD agar for 6e8 hours. The
initial cell morphology was observed to ensure that the strain
was pure; if the morphology was different, we would isolate
each different cell by a micromanipulator to be an FI-SGDS. In
the 87 FI-SGDSs also, each colony was spread on YPD agar for
6e8 hours and the initial cell morphology was observed; each
different cell was isolated to be an FI-TGDS.ces rapid high-frequency MTL homozygosis with microbiological
munology and Infection (2016), http://dx.doi.org/10.1016/
Table 1 Strains used in this study.
Strain Parent strain MTL genotype No. of strains Ratio of DNA
content decrease
Ratio of MTL
homozygositya
SC5314 (n Z 1) a1a1a2 1
FI-FGDS (n Z 35) (first generation) SC5314 a1a1a2 31 4/35 (11.4%) 4/35 (11.4%)
a1 2
a1a2 2
FI-SGDS (n Z 87) (second generation) FI-FGDS a1a1a2 74 12/35 (34.3%) 11/35 (31.4%)
a1 6
a1a2 7
FI-TGDS (n Z 141) (third-generation) FI-SGDS a1a1a2 100 20/35 (57.1%) 17/35 (48.6%)
a1 24
a1a2 17
a The ratios correspond to first-generation FI-FGDSs (see Methods section).
FI-FGDSZ fluconazole-induced first-generation daughter strain; FI-SGDSZ fluconazole-induced second-generation daughter strain; FI-
TGDS Z fluconazole-induced third-generation daughter strain.
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Each strain was spread, at a density of 100e200 cells/mm2, on
a YPD agar plate and incubated for 6e12 hours at 30C to
observe the initial colony morphology. The initial colony
morphology of each strain was observed using a microscope
(Leica DM2500, Leica Microsystems, Germany) and was pho-
tographed using a QICAM Fast1394 device (Qimaging, Canada).
Polymerase chain reaction analysis of MTL gene and
frequency of MTL homozygosis
We used 30 ng of pure genomic DNA. The MTLa1, MTLa1, and
MTLa2 primer sequences and polymerase chain reaction
condition used in this study were according to those used in
previous studies.12,19 Reaction mixtures were typically heat-
ed for 5 minutes at 94C, followed by 30 cycles of 30 seconds
at 94C, 1 minute at 60C, and 1 minute at 72C. After a final
incubation period of 10 minutes at 72C, we stored the re-
action mixtures at 4C. The polymerase chain reaction frag-
ments wer observed by electrophoresis on a 1.5% agarose gel
in 1 Tris-acetate-EDTA (TAE) buffer which is used as both a
running buffer and in agarose gel (Bio-Rad, California, USA) at
100 V for 30 minutes and stained with SYBR Safe DNA gel stain
(Invitrogen, Thermo Fisher Scientific Inc, Waltham, USA). The
frequency of MTL homozygosis corresponded to FI-FGDSs.
Flow cytometry analysis of DNA content
The DNA content of the SC5314 strain and its daughter
strains was analyzed using Sytox Green dye-stained flow
cytometry. The tested strains were propagated at 30C for
24 hours in YPD agar and prepared by fixing in 70% ethanol
at 4C. The cells were washed and suspended in 1 mL
phosphate buffered saline, sonicated on low power, and
then resuspended in 0.5 mL of 2 mg/mL RNaseA solution
and incubated at 37C for 2 hours. The samples were
treated with 5 mg/mL pepsin for 30 minutes at 37C, and
were then suspended in 0.5 mL phosphate buffered saline
and sonicated at low power. The samples were stained in
1mM Sytox Green dye for 1 hour at 4C and then analyzedPlease cite this article in press as: Ou T-Y, et al., Fluconazole indu
polymorphism in Candida albicans, Journal of Microbiology, Im
j.jmii.2015.12.009by flow cytometry. A total of 10,000 cells were analyzed for
each tested strain. Cell and colony morphologies of all the
DNA-decreasing strains were observed and the minimum
inhibitory concentrations (MICs) were determined by the E-
test method, following Lu et al.20
Results
Frequency of MTL homozygotes
In total, 263 strains, 35 FI-FGDSs (harvested from phloxine
B-stained colonies inside the inhibition zone of the
fluconazole-induced assay), 87 FI-SGDSs, and 141 FI-TGDSs,
were obtained and analyzed to determine their MTL geno-
types (Table 1). In the 35 FI-FGDSs, four (11.4%) had lost one
of the MTL genes, and all four of these were MTL homozy-
gous. In 87 FI-SGDSs, there were 13 MTL homozygous strains,
corresponding to FI-FGDSs; the frequency was 11/35 (31.4%).
In 141 FI-TGDSs, there were 41 MTL homozygous strains,
corresponding to 35 FI-FGDSs; the frequency was 17/35
(48.6%) (Table 2). The colonies inside and outside the flu-
conazole inhibition zone were collected, and replated on
PBeYPD agar. The percentages of phloxine B-stained colonies
inside and outside were 24.6% (118/479) and 0.449% (2/445),
respectively. The frequency of phloxine B-stained colonies
increased about 55-fold with fluconazole stress (Figure 1).
Microbiological polymorphism in fluconazole-
induced daughter strains: cell/colony morphology,
DNA content, and antifungal drug susceptibility
Compared with the reference strain SC5314, single colony
and cell morphology were different. All the daughter
strains examined had a lower DNA content than the pro-
genitor SC5314 strain. The six fluconazole-induced MTL
homozygous daughter strains, FI-SGDS-A12-2, FI-FGDS-A14,
FI-SGDS-A17-1, FI-TGDS-A17-1-L2, FI-TGDS-A17-1-R2, and
FI-FGDS-A25, investigated had significantly lower DNA
contents, decreased by more than 40% (Figure 2, Table 2).
Changing microbiological characteristics were found in
fluconazole-induced daughter strains with and without MTLces rapid high-frequency MTL homozygosis with microbiological
munology and Infection (2016), http://dx.doi.org/10.1016/
Table 2 Microbiological characteristics of C. albicans strains with fluconazole treatment.
Strain Parent strain MTL gene Filamentous DNA contenta Fluconazole MICs Amphotericin B MICs
SC5314 a1a1a2 No 1.0 0.125 0.125
FI-FGDS-A12 SC5314 a1a1a2 Yes 0.51 0.125 0.19
FI-SGDS-A12-2 FI-FGDS-A12 a1 Yes 0.53 0.19 0.125
FI-FGDS-A14 SC5314 a1 Yes 0.48 0.125 0.19
FI-FGDS-A17 SC5314 a1a1a2 Yes 0.98 0.19 0.125
FI-SGDS-A17-1 FI-FGDS-A17 a1a1a2 No 0.65 0.25 0.125
FI-TGDS-A17-1-L2 FI-SGDS-A17-1 a1a2 Yes 0.69 0.19 0.064
FI-TGDS-A17-1-R2 FI-SGDS-A17-1 a1 Yes 0.49 0.5 0.125
FI-FGDS-A25 SC5314 a1a2 No 0.58 0.19 0.19
a Based on the G1 peak value of the flow cytometry analysis of the DNA content, the value was normalized to that of SC5314 (2N).
FI-FGDSZ fluconazole-induced first-generation daughter strain; FI-SGDSZ fluconazole-induced second-generation daughter strain; FI-
TGDS Z fluconazole-induced third-generation daughter strain; MIC Z minimum inhibitory concentration.
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MICs of fluconazole in strains FI-SGDS-A17-1 and FI-TGDS-
A17-1-R2 were increased to 0.25 and 0.5, respectively, and
the MIC of amphotericin B in the strain FI-SGDS-A17-L2 was
decreased to 0.064.Figure 1. Phloxine B-stained colonies by fluconazole-induced assay
entially staining them red. (A) Strain SC5314 was treated with a fluco
transitional area was taken with a microscope using a 10 objective to
were collected from (C) inside and (D) outside the inhibition zone, an
inhibition zones in (A) and (B) were all phloxine B-stained colonies (r
inhibition zone, were partially phloxine B-stained (red), and the ratio
Please cite this article in press as: Ou T-Y, et al., Fluconazole indu
polymorphism in Candida albicans, Journal of Microbiology, Im
j.jmii.2015.12.009Discussion
In this study, a fluconazole-induced assay identified four
MTL homozygotes in the 35 first-generation FI-FGDSs, and,
upon further propagation of these strains, we ended up. Phloxine B distinguishes opaque sectors and colonies by differ-
nazole E-test strip on PBeYPD agar. (B) A photomicrograph of the
show the colonies inside and outside the inhibition zones. Colonies
d replated on PBeYPD agar for 7 days at 30C. Colonies inside the
ed). Regrown colonies, taken from (C) inside and (D) outside the
s were 118/479 (24.6%) and 2/445 (0.00449%), respectively.
ces rapid high-frequency MTL homozygosis with microbiological
munology and Infection (2016), http://dx.doi.org/10.1016/
Figure 2. Flow cytometry analysis of DNA content. A was reference diploid strain SC5314, B and C were MTL homozygous strains
without fluconazole treatment. DeK were strains with fluconazole treatment. L was the merged of all strains. The fluconazole-
induced daughter strains, FI-FGDS-A14, FI-SGDS-A17-1, FI-FGDS-A17-1-L2, FI-TGDS-A17-1-R2, and FI-FGDS-A25, had more signifi-
cant decreases in DNA content compared with SC5314, however nonfluconazole-induced daughter strains, LM-MTL-a and LM-MTL-a,
did not. FI-FGDS Z fluconazole-induced first-generation daughter strain; FI-SGDS Z fluconazole-induced second-generation
daughter strain; FI-TGDS Z fluconazole-induced third-generation daughter strain.
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rence (48.6%) of MTL homozygosity in C. albicans. The FI-
FGDSs were collected from fluconazole stress for 12e16
hours, but the FI-SGDSs and FI-TGDSs were collected from
PBeYPD plates without fluconazole. These results revealed
that short-term treatment with fluconazole affected at least
three generations of C. albicans. We speculate that C. albi-
cansmay encounter a genetically unstable period in changing
chromosome number, together with possibly decreasing their
DNA content, under fluconazole stress. Thus, the early-stage
colonies may not have been able to survive fluconazole stress
unless they were rescued from the stress in a timely manner.
In our study, fluconazole-induced SC5314 daughter strains
were found to have a much higher MTL homozygosity ratio
(48.6%) than that found in nature using Lee’s medium assay
(0.14%) or observed with clinical strains (3.2%).
Fluconazole, one of the most common antifungal drugs
used to treat fungal infections caused by C. albicans, isPlease cite this article in press as: Ou T-Y, et al., Fluconazole indu
polymorphism in Candida albicans, Journal of Microbiology, Im
j.jmii.2015.12.009known to be an inhibitor of lanosterol 14-alpha-demethy-
lase, which interferes with ergosterol biosynthesis.11 The
proportion of MTL homozygotes in our study was much
higher than that found in clinical isolates, although the
clinical use of fluconazole to treat C. albicans infections is
very common. The mechanisms by which MTL homozygosity
is rapidly induced by fluconazole in C. albicans are random
chromosome loss and unequal division in mitosis. Two hy-
potheses may explain the different proportions of MTL
homozygotes in our study compared with clinical isolates.
The first assumes that fluconazole-induced MTL homozy-
gotes have good mating ability. Therefore, most of them
mate quickly with homozygotes for the complementary
allele in the host environment, and their offspring are
identified as MTL heterozygotes that actually genetically
differ from the initial heterozygotes. The second hypothe-
sis is that most of the fluconazole-induced homozygotes
vanish in the host environment because of fluconazoleces rapid high-frequency MTL homozygosis with microbiological
munology and Infection (2016), http://dx.doi.org/10.1016/
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In previous studies, MTL-a and MTL-a homozygotes were
demonstrated to mate in a mouse model, and heterozy-
gotes adapted better to the host environment, thereby
becoming the predominant population. These observations
partially support our two hypotheses of the homozygotes
either mating quickly or dying out.
Additional microbiological characterization of the pro-
genitor strain SC5314 and some of the fluconazole-induced
daughter strains was conducted. Dramatic microbiological
changes were found in the daughter strains investigated.
These alterations included cell/colony polymorphism in
some of the daughter strains, decreased or increase DNA
content in the strains, and modified antifungal drug sus-
ceptibility. Rapid microbiological changes with poly-
morphisms and a high frequency of MTL homozygosity in
the fluconazole assay suggest a capacity of this yeast for
rapid evolution, especially if fluconazole-induced MTL ho-
mozygotes are mating competent. In summary, fluconazole
treatment inhibited the growth of C. albicans and altered
its microbiological characteristics. High-frequency MTL
homozygosity was identified inside the fluconazole inhibi-
tion zone within 24 hours. The DNA content of the daughter
strains was reduced compared with that of the progenitor
SC5314 strain and heterozygous strains, suggesting chro-
mosome loss induced by fluconazole treatment. The
mechanism will induce the rapid evolution and produce
fluconazole-resistant strains in C. albicans. The present
study provides new insights into the interactions between
the pathogenic C. albicans fungus and the antifungal drug
fluconazole. In clinical treatment, inappropriate dosage of
fluconazole will increase the evolution and produce
fluconazole-resistant strains. These novel data may be
helpful in the future to better manage patients infected
with C. albicans. In addition, the unexpected action of
fluconazole on C. albicans can be leveraged in future
models in microbiological studies.
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